Literature DB >> 9001404

Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery.

K Hong1, W Zheng, A Baker, D Papahadjopoulos.   

Abstract

Stable complexes of cationic liposomes with plasmid DNA were prepared by (1) including a small amount of poly(ethylene glycol)-phospholipid conjugate or (2) condensing the DNA with polyamines prior to the formation of liposome-plasmid complexes. These preparations were stable for months at 4 degrees C and gave reproducible high transfection activity for in vivo gene delivery after intravenous injection in mice. Under these conditions, the expression of marker gene (luciferase) was primarily in the lungs (reaching values up to 3 ng expression per mg tissue protein), but also in other tissues to a lesser extent. Non-stabilized formulations lost all their transfection activity in 4 days. In these formulations cholesterol, not dioleoylphosphatidylethanolamine, was the helper lipid effective for sustaining high transfection activity in vivo. These new developments in formulation technology should enhance the potential for liposome-mediated gene therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9001404     DOI: 10.1016/s0014-5793(96)01397-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  46 in total

Review 1.  New directions in liposome gene delivery.

Authors:  N S Templeton; D D Lasic
Journal:  Mol Biotechnol       Date:  1999-04       Impact factor: 2.695

2.  New bicompartmental structures are observed when stearylamine is mixed with triglyceride emulsions.

Authors:  H Teixeira; C Dubernet; V Rosilio; S Benita; J Lepault; I Erk; P Couvreur
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

3.  A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy.

Authors:  J A Iñiguez-Lluhí; D Pearce
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

4.  Improved DNA/emulsion complex stabilized by poly(ethylene glycol) conjugated phospholipid.

Authors:  S Chesnoy; D Durand; J Doucet; D B Stolz; L Huang
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

Review 5.  Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

6.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  R M Nissen; K R Yamamoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

7.  Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein.

Authors:  A Abe; A Miyanohara; T Friedmann
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 8.  DNA-antiviral vaccines: new developments and approaches--a review.

Authors:  M Giese
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

9.  Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer.

Authors:  G Salzano; R Riehle; G Navarro; F Perche; G De Rosa; V P Torchilin
Journal:  Cancer Lett       Date:  2013-10-04       Impact factor: 8.679

10.  Questioning the Use of PEGylation for Drug Delivery.

Authors:  Johan J F Verhoef; Thomas J Anchordoquy
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.